Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Porphyromonas gingivalis 60 kDa heat shock protein (Hsp60), also known as GroEL, is a critical molecular chaperone essential for the folding and stability of bacterial proteins under physiological and stress conditions [5, 7]. Beyond its intracellular maintenance role, Hsp60 is a major virulence factor that is surface-expressed and secreted, making it highly immunogenic and accessible to the host immune system [3, 15]. It is central to the 'molecular mimicry' hypothesis, where high sequence homology between the bacterial Hsp60 and human Hsp60 leads to a cross-reactive immune response that contributes to the pathogenesis of atherosclerosis and rheumatoid arthritis [2, 12, 16]. In addition to its role in chronic inflammation, the protein can promote tumor growth by enhancing neovascularization and inducing endothelial dysfunction [10, 4]. While it is a promising target for periodontal vaccines and a diagnostic biomarker for systemic disease risk, its high similarity to host proteins presents significant safety challenges for therapeutic development, particularly the risk of inducing or worsening autoimmune conditions [7, 18, 21].
Experimental vaccines aim to induce protective opsonophagocytosis and immune clearance of Porphyromonas gingivalis while avoiding epitopes that trigger cross-reactive autoimmune responses. Research-grade inhibitors and antibodies work by blocking the pro-inflammatory signaling and endothelial dysfunction pathways (such as eNOS downregulation and caspase-3 activation) triggered by the protein in host cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60 kDa heat shock protein (GroEL) (Hsp60).